Anaplastic lymphoma kinase

Results: 91



#Item
21Drug Discovery Case History  1. Introduction

Drug Discovery Case History 1. Introduction

Add to Reading List

Source URL: www.brimr.org

Language: English - Date: 2013-07-01 10:35:04
22Anaplastic lymphoma kinase (ALK): Structure, oncogenic activation, and pharmacological inhibition

Anaplastic lymphoma kinase (ALK): Structure, oncogenic activation, and pharmacological inhibition

Add to Reading List

Source URL: www.brimr.org

Language: English - Date: 2012-12-23 16:51:41
23

PDF Document

Add to Reading List

Source URL: www.amp.org

Language: English - Date: 2010-11-01 17:47:52
24Lung cancer / Crizotinib / Organofluorides / Piperidines / Pyrazoles / Pyridines / Pharmaceutical Benefits Scheme / Anaplastic lymphoma kinase / Non-small-cell lung carcinoma / Medicine / Chemistry / Health

4.1 CRIZOTINIB 200 mg capsule, 60 and 250 mg capsule, 60; Xalkori®; Pfizer Australia Pty Ltd. 1 Purpose of Application

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-03-16 01:05:14
25Microsoft WordcrizotinibRedacted PSD Final.docx

Microsoft WordcrizotinibRedacted PSD Final.docx

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-03-23 21:11:42
26Public Summary Document – November 2014 PBAC Meeting  4.1 CRIZOTINIB 200 mg capsule, 60 and 250 mg capsule, 60;

Public Summary Document – November 2014 PBAC Meeting 4.1 CRIZOTINIB 200 mg capsule, 60 and 250 mg capsule, 60;

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-03-16 01:05:14
27October 24, 2012  Astex Pharmaceuticals Announces Initiation of AT13387 Phase 2 Study in Non-Small Cell Lung Cancer DUBLIN, Calif., Oct. 24, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceu

October 24, 2012 Astex Pharmaceuticals Announces Initiation of AT13387 Phase 2 Study in Non-Small Cell Lung Cancer DUBLIN, Calif., Oct. 24, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceu

Add to Reading List

Source URL: astx.com

Language: English
28Lung cancer / Organofluorides / Organochlorides / Anatomical pathology / Crizotinib / Pyrazoles / Non-small-cell lung carcinoma / Anaplastic lymphoma kinase / ALK inhibitor / Medicine / Chemistry / Oncology

Public Summary Document Application No[removed] – Testing of the anaplastic lymphoma kinase (ALK) gene in patients with non–small cell lung cancer to determine eligibility for treatment with crizotinib

Add to Reading List

Source URL: www.msac.gov.au

Language: English - Date: 2015-04-16 01:23:53
2913163 CONCEPT Area A March 2014.indd

13163 CONCEPT Area A March 2014.indd

Add to Reading List

Source URL: www.katanning.wa.gov.au

Language: English - Date: 2014-08-14 03:20:02
30ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1  This medicinal product is subject to additional monitoring. This will allow quick identification of

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 This medicinal product is subject to additional monitoring. This will allow quick identification of

Add to Reading List

Source URL: www.ema.europa.eu

Language: English - Date: 2015-03-16 11:38:36